Get Living Without's FREE Recipe of the Week

Delicious allergy-friendly recipes for you and your family

FeaturesDec/Jan 2014 Issue

All About Epinephrine

Fear of Injection

Dooms would like people to be more comfortable administering epinephrine.

“There are a lot of psychological barriers to using the device,” says Dooms, who is a member of the adverse reactions to foods committee of the American Academy of Allergy, Asthma & Immunology (AAAAI). “It seems as if in a clutch situation when there’s a severe reaction, whether it be at school, on a field trip or even at home, a lot of people will suddenly become more afraid of the auto-injector than they are of anaphylaxis.”

He is concerned that some school staff and caregivers worry they might hurt the child with the auto-injector needle or that children are afraid of the needle. This delays administration of epinephrine, which increases the risk of a fatal reaction.

“The benefits of using emergency epinephrine outweigh the risks of an unnecessary dose,” Dooms says.

People with life-threatening allergies certainly have more choices than they did 25 years ago, when epinephrine was administered with a vial and syringe. The landscape changed for the drug when a former NASA engineer developed the EpiPen auto-injector. Now three brands of auto-injectors are available in the United States — EpiPen, Auvi-Q and Adrenaclick, plus the option for a generic version. The auto-injectors come in junior and adult doses.

Some of the design features of Auvi-Q, a new auto-injector introduced in January 2013, address the fear of using the medication. The device is the size and shape of a credit card and the thickness of a smartphone. It features a retractable needle and voice-guided instructions, as well as visual cues, to walk and talk you through the injection process. A mobile phone app for Auvi-Q turns your phone into a trainer, allowing you to show a video, as well as set up allergy profiles for every family member with a severe allergy.

In September, a partnership of two pharmaceutical companies announced it is working on a formulation for nasally delivered epinephrine. Still in very preliminary development, the device is aimed at treating anaphylaxis in those who are needle-phobic.

Next: Emergency Training

Comments (0)

Be the first to comment on this post using the section below.

Add your comments ...

New to Living Without?
Register for Free!

Already Registered?
Log In